[Effectiveness and pharmacodynamics of tobanum in patients with paroxysmal reciprocal atrioventricular tachycardia]

Kardiologiia. 1991 Jul;31(7):45-7.
[Article in Russian]

Abstract

The antiarrhythmic effects and pharmacodynamics of tobanum were evaluated in 28 patients wist paroxysms of reciprocal atrioventricular tachycardia, by using transesophageal cardiac pacing. The agent given in a single dose of 10 mg produced antiarrhythmic effects in 70% patients with paroxysms of atrioventricular nodal tachycardia and in 40% with atrioventricular tachycardia in the presence of the Wolff--Parkinson-White syndrome. After administration of the drug, its antiarrhythmic effect occurred on an average 1.5 h and retained for 27 h.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Aged
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrioventricular Node / drug effects*
  • Atrioventricular Node / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Placebos
  • Propanolamines / therapeutic use*
  • Tachycardia, Atrioventricular Nodal Reentry / drug therapy*
  • Tachycardia, Atrioventricular Nodal Reentry / physiopathology
  • Tachycardia, Paroxysmal / drug therapy*
  • Tachycardia, Paroxysmal / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Placebos
  • Propanolamines
  • tobanum